Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists (opens ClinicalTrials.gov)
- Sponsor
- Ohio State University
- Enrolment
- 300
- Started
- 2026-06-12
- Last update
- 2026-07-24
Conditions: Obesity & Overweight, Diabetes (DM)
Interventions: Glucagon-Like Peptide-1 Agonist (GLP-1)